Grace Therapeutics, Inc.

GRCE · NASDAQ
Analyze with AI
3/31/2025
3/31/2024
3/31/2023
3/31/2022
Assets
Cash & Equivalents$22,133$23,005$27,875$30,339
Short-Term Investments$0$0$15$13,322
Receivables$126$722$802$548
Inventory$0$0$0$0
Other Curr. Assets$453$283$598$1,322
Total Curr. Assets$22,712$24,010$29,290$45,531
Property Plant & Equip (Net)$15$24$567$315
Goodwill$8,138$8,138$8,138$12,964
Intangibles$41,128$41,128$41,128$69,810
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$0$0$0$0
Total NC Assets$49,281$49,290$49,833$83,089
Other Assets$0$0$0$0
Total Assets$71,993$73,300$79,123$128,620
Liabilities
Payables$601$1,007$1,242$3,156
Short-Term Debt$0$0$75$104
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$1,329$677$2,094$0
Total Curr. Liab.$1,930$1,684$3,411$3,260
LT Debt$0$0$410$191
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$2,312$5,514$7,347$16,889
Other NC Liab.$1,141$4,359$0$10
Total NC Liab.$3,453$9,873$7,757$17,090
Other Liabilities$0$0$0$0
Cap. Leases$0$0$410$191
Total Liabilities$5,383$11,557$11,168$20,350
Equity
Pref Stock$0$0$0$0
Common Stock$1$261,038$258,294$257,990
Retained Earnings-$220,687-$211,119-$198,266-$155,837
AOCI-$6,038-$6,038-$6,038-$6,037
Other Equity$293,334$17,862$13,965$12,154
Total Equity$66,610$61,743$67,955$108,270
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$71,993$73,300$79,123$128,620
Net Debt-$22,133-$23,005-$27,390-$30,044